Skip to content

Evaluation of the effect of zero opiates in thoracic surgery

Evaluation of the effect of zero opiates in thoracic surgery

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050032
Enrollment
Unknown
Registered
2021-08-16
Start date
2021-08-16
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Opioid group:Opioids
Zero opioids group:Zero opioids

Sponsors

Affiliated Hospital of Jiaxing College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Source of study subjects and expected number of cases: Thoracic surgery was performed in Jiaxing First Hospital from August 2021 to November 2021. The operation time was >90 min. There were 200 patients, aged 18-80 years, with ASA grades I-III.

Exclusion criteria

Exclusion criteria: 1. The operation is only performed under local anesthesia, regional anesthesia or anesthesia monitoring; 2. The patient refused to participate in the experiment; 3. There is a history of chronic pain or symptoms of chronic pain; 4. Patients who died during or immediately after surgery; 5. Patients with severe liver and kidney insufficiency and severe abnormal coagulation function; 6. Allergy to anesthetics.

Design outcomes

Primary

MeasureTime frame
Recovery quality score;Opioid dosage;Incidence of nausea and vomiting;

Secondary

MeasureTime frame
Numerical Rating Scale;General basic patient information;Patient's vital signs;Remifentanil dosage;Dosage of propofol and sevoflurane;

Countries

China

Contacts

Public ContactZhou Qinghe

Affiliated Hospital of Jiaxing College

dengwei1992868@163.com+86 13732573379

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026